Cipla Limited, headquartered in Mumbai, India, is a globally recognized
manufacturer, exporter, and service provider in the pharmaceutical and healthcare sectors. Serving respiratory, cardiovascular, anti-infective, HIV/AIDS, oncology, CNS, and consumer health industries, Cipla operates 47 manufacturing sites and distributes over 1,500 products across 80+ countries with a strong presence in India, North America, South Africa, and emerging markets.
Cipla's product portfolio includes
generic and complex generics (tablets, injectables, inhalers, topicals) across key therapies—respiratory (Salbutamol, Formoterol/Budesonide), cardiovascular, diabetes, oncology, CNS, urology, and anti-infectives. It’s the world’s largest
ARV manufacturer, offers
biosimilars in collaboration with Kemwell and Alvotech,
consumer health and OTC products, APIs, and digital health solutions—with strong pipeline in biosimilars, specialty, and diagnostics backed by robust R&D.
* This phone number available for 3 min is not the recipient’s number but a number from a service which will put you through to that person.
This service is produced by Kompass.
Service & free calls*
* This number, only available 3 minutes, is not your correspondant’s number but the number of a service putting you through to that person.This service is produced by Kompass.
All-in-one prospecting solution designed to improve your productivity
×
Find your next customer today! Your shortcut to faster, more targeted and successful lead generation
Register for free and turn reliable data into real business opportunities
Your data is used to recontact you or send you communications and may be processed by Kompass, for the purposes of legitimate interest (Article 6 1.f of the GDPR). You may object to its processing by email: dpo@kompass.com.
